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Young people have the right to evidence based
interventions. We know from the past that many well
meaning attempts to do good resulted in harm, but we
now have the means through systematic review, trials,
sound evaluations, and good qualitative work, to do
better.
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Where is the evidence that animal research benefits
humans?
Pandora Pound, Shah Ebrahim, Peter Sandercock, Michael B Bracken, Ian Roberts on behalf of the
Reviewing Animal Trials Systematically (RATS) Group
Much animal research into potential treatments for humans is wasted because it is poorly conducted
and not evaluated through systematic reviews
Clinicians and the public often consider it axiomatic
that animal research has contributed to the treatment
of human disease, yet little evidence is available to sup-
port this view. Few methods exist for evaluating the
clinical relevance or importance of basic animal
research, and so its clinical (as distinct from scientific)
contribution remains uncertain.1 Anecdotal evidence
or unsupported claims are often used as justification—
for example, statements that the need for animal
research is “self evident”2 or that “Animal experimenta-
tion is a valuable research method which has proved
itself over time.”3 Such statements are an inadequate
form of evidence for such a controversial area of
research. We argue that systematic reviews of existing
and future research are needed.
Assessing animal research
Despite the lack of systematic evidence for its effective-
ness, basic animal research in the United Kingdom
receives much more funding than clinical research.1 4 5
Given this, and because the public accepts animal
research only on the assumption that it benefits
humans,6 the clinical relevance of animal experiments
needs urgent clarification.
Several methods are available to evaluate animal
research. These include historical analysis,7 critiques of
animal models,8 investigations into the development of
treatments,5 surveys of clinicians’ views,9 and citation
analyses.10 However, perhaps the best way of producing
evidence about the value of animal research is to con-
duct systematic reviews of animal studies and, where
possible, compare the results of these with the results
of the corresponding clinical trials. So what do studies
that have done this show?
Details of the search strategy and references w1-w18 are on
bmj.com
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Systematic reviews of animal research
We searched Medline to identify published systematic
reviews of animal experiments (see bmj.com for the
search strategy). The search identified 277 possible
papers, of which 22 were reports of systematic reviews.
We are also aware of one recently published study and
two unpublished studies, bringing the total to 25.
Three further studies are in progress (M Macleod, per-
sonal communication).
Seven of the 25 papers were systematic reviews of
animal studies that had been conducted to find out
how the animal research had informed the clinical
research. Two of these reported on the same group of
studies, giving six reviews in this category. A further 10
papers were systematic reviews of animal studies
conducted to assess the evidence for proceeding to
clinical trials or to establish an evidence base.w1-w10 Eight
systematically reviewed both the animal and human
studies in a particular field, again before clinical trials
had taken place.w11-w18 We focus on the six studies in the
first category because these shed the most light on the
contribution that animal research makes to clinical
medicine.
Calcium channel blockers for stroke
The first systematic review of animal research, by Horn
and colleagues,11 was conducted after their systematic
review of clinical trials of nimodipine for acute stroke
found no evidence of a clinically important effect.12
Their review of the animal experiments with
nimodipine found no convincing evidence of benefit
to support the decision to start clinical trials. Horn et al
also found that the methodological quality of the
animal studies included in the review was poor,
commenting on the infrequency of randomisation of
animals, lack of blinded assessment, and failure to
measure outcomes beyond the acute phase. Further-
more, the animal and clinical studies of nimodipine
ran simultaneously rather than sequentially, as would
be expected if the animal experiments were to inform
the human trials.
Low level laser therapy for wound healing
Lucas et al investigated the basis for clinical trials of low
level laser therapy to improve wound healing after the
treatment was found ineffective in humans.13 The
authors found that the animal studies did not provide
unequivocal evidence to substantiate the decision to
conduct clinical trials, that the methodological quality
of the animal studies was poor, and that animal and
clinical studies were conducted simultaneously rather
than sequentially. They commented on the relevance
of the animal models to the real clinical situations,
noting that the animal models excluded common
problems associated with wound healing in humans
such as ischaemia, infection, and necrotic debris.
Fluid resuscitation for bleeding
Roberts et al14 and Mapstone et al15 assessed the animal
evidence in support of fluid resuscitation for bleeding
trauma patients. Their systematic review of clinical
trials of fluid resuscitation had previously found no
evidence that the practice improved outcome and the
possibility that it might be harmful.16 The review of
animal research found that the fluid resuscitation
reduced the risk of death in animal models of severe
haemorrhage but increased the risk of death in those
with less severe haemorrhage. They concluded that
excessive fluid resuscitation in animals can be harmful
in some situations.
The review again highlighted the poor method-
ological quality of individual animal studies. Moreover,
because the animal experiments were small, the effect
estimates from these studies were imprecise. The
authors argued that systematic reviews and meta-
analyses of previous animal experiments would ensure
that new animal experiments do not set out to answer
questions that have already been answered and, by
increasing the precision of estimates of treatment
effects, could reduce the number of animals needed in
future experiments.
Thrombolysis for stroke
An unpublished study by Ciccone and Candelise
systematically reviewed randomised controlled experi-
ments of animal stroke models that compared the
effects of thrombolytic drugs with placebo or open
control.17 The background to the study was the finding
that clinical trials of thrombolysis for acute stroke had
found a substantial excess risk of intracranial haemor-
rhage that had not been predicted by individual animal
studies. When the animal data were pooled, a
significant difference was found in the rate of intracra-
nial haemorrhage between animals in the control and
treatment groups.
Stress and coronary heart disease
Petticrew and Davey Smith examined randomised and
observational studies of the effects of hierarchies and
stress on coronary heart disease in primates.18 They
found no convincing evidence of a relation between
social status and experimentally induced stress and
coronary heart disease. Among male primates,
dominant rather than subordinate social position
seemed to be associated with heart disease, contradict-
ing a large body of observational epidemiological
studies of stress and coronary heart disease.19 The
authors noted that social epidemiologists had cited
only the studies that supported their prior views of a
positive association and had ignored studies with
negative results. Within psychosocial epidemiology,
citation was highly selective, producing the misleading
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impression that primate studies support the view that
the health effects of inequality are manifest through
psychosocial mechanisms. The authors concluded that
the primate data do not support such major public
health claims.
Endothelin receptor blockade in heart failure
Lee and colleagues20 conducted a systematic review
and meta-analysis of controlled trials of endothelin
receptor blockade in animal models of heart failure,
after clinical trials in humans had found no evidence
of benefit. They found that the animal studies were
small and poorly designed with inconsistent use of
randomisation and blinding. Pooled analyses of the
animal data provided no evidence of benefit overall
and showed a tendency towards increased mortality
with early administration. The authors called for
greater use of systematic reviews in preclinical drug
evaluation.
Implications
The clinical trials of nimodipine and low level laser
therapy were conducted concurrently with the animal
studies, while the clinical trials of fluid resuscitation,
thrombolytic therapy, and endothelin receptor block-
ade went ahead despite evidence of harm from the
animal studies. This suggests that the animal data were
regarded as irrelevant, calling into question why the
studies were done in the first place and seriously
undermining the principle that animal experiments
are necessary to inform clinical medicine.
Furthermore, many of the existing animal experi-
ments were poorly designed. Animal experiments can
inform decisions about what treatments should be
taken forward in clinical trials only if their results are
valid and precise and if the animal studies are
conducted before clinical trials are started. Biased or
imprecise results from animal experiments may result
in the testing of biologically inert or even harmful sub-
stances in clinical trials, thus exposing patients to
unnecessary risk and wasting scarce research funds.
Moreover, if animal experiments fail to informmedical
research, or if the quality of the experiments is so poor
as to render the findings inconclusive, the research will
have been conducted unnecessarily. Investigating the
validity of animal experiments is therefore essential for
both human health and animals.
Although randomisation and blinding are accepted
as standard in clinical trials, no such standards exist for
animal studies.21 Bebarta et al found that animal studies
that did not report randomisation and blinding were
more likely to report a treatment effect than studies
that used these methods.21 The box summarises further
potential methodological problems.
Even if animal experiments provide valid results
and sufficiently precise estimates of treatment effects to
discount the effects of chance, the extent to which the
results can reasonably be generalised to humans
remains open to question. Perhaps it was because of
this uncertainty that the data from animal studies were
disregarded in the above cases.
Conclusion
The contribution of animal studies to clinical medicine
requires urgent formal evaluation. Systematic reviews
and meta-analyses of the existing animal experiments
would represent an important step forward in this
process. Systematic reviews (particularly cumulative
meta-analyses of ongoing experiments22) could more
efficiently determine when a valid conclusion has been
reached from the animal studies. The UK Medical
Research Council requires researchers who are
planning clinical trials to reference systematic reviews
of previous related work.23 A requirement to reference,
or where necessary conduct, systematic reviews of
relevant animal studies before clinical trials would
make it difficult to disregard or selectively cite the evi-
dence from animal studies, or for animal and human
trials to proceed simultaneously.
By ensuring that animal experiments do not set out
to answer questions that have already been answered,
systematic reviews support the principle of reduction.
This principle, outlined in the “three Rs,” (reduction
and replacement of animals and refinement of proce-
dures), is held to be a cornerstone of animal research.24
Systematic reviews would also be relevant in veterinary
medicine to evaluate the efficacy of treatments for sick
animals.
Systematic reviews of animal research would
increase the precision of estimated treatment effects
used in calculating the power of proposed human
trials, reducing risk of false negative results. They are
able to throw light on the process of translation (or its
lack) between animal and clinical research as well
offering the opportunity to review the appropriateness
of the animal models used. Finally, the results of the
animal and human research need to be compared to
see how well one predicts the other.
In the 1970s Comroe and Dripps conducted an
ambitious study to determine the relative contributions
of basic and clinical research to important medical
Methodological problems of animal
experiments
• Disparate animal species and strains, with a variety
of metabolic pathways and drug metabolites, leading
to variation in efficacy and toxicity
• Different models for inducing illness or injury with
varying similarity to the human condition
• Variations in drug dosing schedules and regimen
that are of uncertain relevance to the human
condition
• Variability in the way animals are selected for study,
methods of randomisation, choice of comparison
therapy (none, placebo, vehicle), and reporting of loss
to follow up
• Small experimental groups with inadequate power,
simplistic statistical analysis that does not account for
potential confounding, and failure to follow intention
to treat principles
• Nuances in laboratory technique that may influence
results may be neither recognised nor reported—eg
methods for blinding investigators
• Selection of a variety of outcome measures, which
may be disease surrogates or precursors and which
are of uncertain relevance to the human clinical
condition
• Length of follow up before determination of disease
outcome varies and may not correspond to disease
latency in humans
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advances.25 They concluded that 62% of key articles
that led to advances were the result of basic research. In
the 1980s Smith highlighted many of the method-
ological shortcomings of Comroe and Dripps’ study.26
He concluded that the study was unscientific but that
the main lesson to be gained is that research itself
needs to be researched so that scarce funds can be
allotted more intelligently rather than on the basis of
anecdotal evidence. More recently, Grant et al noted
that Research Council expenditure on basic research
increased in the United Kingdom from 42% of the
total civil research and development in 1991-2 to 61%
in 1998-9.5 While recognising that it would be difficult
to attribute this increase to the work of Comroe and
Dripps, they observe that their study is often quoted in
support of increased funding for basic biomedical
research. Grant et al attempted to replicate the
Comroe and Dripps study and found that it was “not
repeatable, reliable, or valid and thus is an insufficient
evidence base for increased expenditure on basic
biomedical research.”5
The Cochrane and Campbell Collaborations for
systematically reviewing evidence in health care and
social science offer models for how the literature on
animal experiments might be systematically organised
and examined.27 28 Several sources of potential bias
exist in systematic reviews—for example, pharmaceuti-
cal industry animal trials are likely to be excluded from
the public domain for commercial reasons, resulting in
publication bias in systematic reviews—but space
precludes considering them here. Ideally, new animal
studies should not be conducted until the best use has
been made of existing animal studies and until their
validity and generalisability to clinical medicine has
been assessed.
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manuscript.
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Summary points
The value of animal research into potential
human treatments needs urgent rigorous
evaluation
Systematic reviews can provide important insights
into the validity of animal research
The few existing reviews have highlighted
deficiencies such as animal and clinical trials
being conducted simultaneously
Many animal studies were of poor
methodological quality
Systematic reviews should become routine to
ensure the best use of existing animal data as well
as improve the estimates of effect from animal
experiments
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